سعر فيرنيلار 5 مجم 20 قرص 2024

• Relief of symptoms associated with allergic rhinitis (adults and adolescents 12 years and older).Population: Adults and adolescents 12 years and olderelectronic medicines compendium (eMC)
• Relief of symptoms associated with urticaria (adults and adolescents 12 years and older).Population: Adults and adolescents 12 years and olderelectronic medicines compendium (eMC)

• Most frequent adverse reactions in excess of placebo at 5 mg daily: fatigue (1.2%), dry mouth (0.8%) and headache (0.6%). Very rare: hypersensitivity reactions (anaphylaxis, angioedema), tachycardia, palpitations, seizures, liver enzyme elevations and hepatitis.International label, same formulation · electronic medicines compendium (eMC)

• Hypersensitivity to desloratadine, to loratadine or to any excipient.International label, same formulation · electronic medicines compendium (eMC)

• Use with caution in patients with a personal or family history of seizures, particularly young children; consider stopping if a seizure occurs.International label, same formulation · electronic medicines compendium (eMC)
• UK tablets contain lactose; not for patients with rare hereditary galactose intolerance, total lactase deficiency or glucose-galactose malabsorption (Egyptian excipients not verified).International label, same formulation · electronic medicines compendium (eMC)

• AlcoholDid not potentiate alcohol-related performance impairment in a clinical pharmacology study, but alcohol intolerance and intoxication have been reported post-marketing; caution with alcohol.electronic medicines compendium (eMC)
• Erythromycin or ketoconazoleNo clinically relevant interactions were observed in clinical trials.electronic medicines compendium (eMC)

• Data from more than 1,000 pregnancy outcomes indicate no malformative or foeto/neonatal toxicity; as a precaution, use during pregnancy is preferably avoided.International label, same formulation · electronic medicines compendium (eMC)
• Desloratadine has been found in breastfed infants of treated women; decide whether to stop breastfeeding or therapy considering benefits to child and mother.International label, same formulation · electronic medicines compendium (eMC)

English text not available for this section.